Literature DB >> 6797788

The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora.

S Roy, J Wilkins, D R Mishell.   

Abstract

Premenopausal women seeking a steroid contraceptive method were allowed to choose between a contraceptive vaginal ring (CVR) containing levonorgestrel and estradiol used in a 3-week in, 1-week out regimen (n=20) and an oral contraceptive (OC) containing levonorgestrel and ethinyl estradiol in a 28-day regimen (n = 10). Cultures from the posterior vaginal fornix were obtained before therapy in both groups and monthly for 6 months for the CVR group and after 1, 3, and 6 months for the OC group. These cultures were streaked on specific media to provide quantitative aerobic and anaerobic, lactobacillus, Candida sp., Gardnerella vaginalis and Neisseria gonorrhoeae counts in micro-organisms per milliliter. A comparison of the number and types of organisms isolated from vaginal cultures obtained initially and at 6 months demonstrated no statistically significant differences in colony counts between CVR and OC users. The results of this study suggest that the use of the CVR is not associated with a greater growth of pathogens than is oral administration of a progestin and estrogen combination.

Entities:  

Keywords:  Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Methods--side effects; Ethinyl Estradiol; Family Planning; Genitalia; Genitalia, Female; Histology; Laboratory Procedures; Levonorgestrel; Oral Contraceptives--side effects; Parity; Physiology; Urogenital System; Vagina--changes; Vaginal Rings

Mesh:

Substances:

Year:  1981        PMID: 6797788     DOI: 10.1016/0010-7824(81)90011-1

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

1.  Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women.

Authors:  Liselotte Hardy; Vicky Jespers; Irith De Baetselier; Jozefien Buyze; Lambert Mwambarangwe; Viateur Musengamana; Janneke van de Wijgert; Tania Crucitti
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

2.  Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.

Authors:  Andrea Ries Thurman; Jill L Schwartz; Jacques Ravel; Pawel Gajer; Mark A Marzinke; Nazita Yousefieh; Sharon M Anderson; Gustavo F Doncel
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

3.  Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring.

Authors:  Andrea R Thurman; Jacques Ravel; Pawel Gajer; Mark A Marzinke; Louise A Ouattara; Terry Jacot; M Melissa Peet; Meredith R Clark; Gustavo F Doncel
Journal:  Front Cell Infect Microbiol       Date:  2022-03-08       Impact factor: 5.293

4.  Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation.

Authors:  Yongmei Huang; Ruth B Merkatz; Sharon L Hillier; Kevin Roberts; Diana L Blithe; Régine Sitruk-Ware; Mitchell D Creinin
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.